2018
Ruzin A, Pastula ST , Levin-Sparenberg E, Jiang X , Fryzek J, Tovchigrechko A, Lu B, Qi Y, Liu H, Jin H, Yu L, Hackett J, Villafana T, Esser MT. 2018. Characterization of circulating RSV strains among subjects in the OUTSMART-RSV surveillance program during the 2016-17 winter viral season in the United States. PLoS One 13(7):e0200319.
View Abstract
Topics: Epidemiology , Pharmaceutics and Medical Devices
Jensen IS, Wu E, Sacks NC , Cyr PL , Chung KC. 2018. Budget impact analysis of using daunarubicin-cytarabine liposome in patients with newly diagnosed therapy-related AML or AML and myelodysplasia-related changes. Am Health Drug Benefits 11(7):380–386. PMID: 30647825 .
View Abstract
Topics: Epidemiology , Health Economics and Outcomes Research (HEOR)
Beebe-Dimmer JL, Ruterbusch JJ, Bylsma LC , Gillezeau C, Fryzek J, Schultz NM, Flanders SC, Barlev A, Heath E, Quek RGW. 2018. Patterns of bicalutamide use in prostate cancer treatment: A U.S. real-world analysis using the SEER-Medicare database. Adv Ther 35(1):1438-1451.
View Abstract
Topics: Cancer , Epidemiology , Pharmaceutics and Medical Devices
Schwartz KL, Simon MS, Bylsma LC , Ruterbusch JJ, Beebe-Dimmer JL, Schultz NM, Flanders SC, Barlev A, Fryzek JP, Quek RGW. 2018. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States. Cancer 124(10):2104-2114.
View Abstract
Topics: Cancer , Epidemiology , Pharmaceutics and Medical Devices
Fryzek JP, Reichert H , Summers N, Townes L, Deuson R, Alexander DD, Vanderpuye-Orgle J. 2018. Indirect treatment comparison of cabazitaxel for patients with metastatic castrate-resistant prostate cancer who have been previously treated with a docetaxel-containing regimen. PLoS One 13(4):e0195790.
View Abstract
Topics: Cancer , Epidemiology , Pharmaceutics and Medical Devices
Sacks NC , Sharma A, Cyr PL , Bertiger G, Dahdal DN, Brogadir S. 2018. Real-world evidence comparison of the efficacy and safety of different bowel preparation agents in a high-risk population. Gastrointest Endosc 87(6) Suppl:AB366.
View Abstract
Topics: Epidemiology
Sacks NC , Sharma A, Cyr PL , Bertiger G, Dahdal DN, Brogadir S. 2018. Real-world comparison of the effectiveness and safety of different bowel preparation agents. Clin Exp Gastroenterol 11:289–299.
View Abstract
Topics: Epidemiology
Sacks NC , Sharma A, Cyr PL , Bertiger G, Dahdal DN, Brogadir S. 2018. Real-world comparison of the effectiveness and safety of different bowel preparation agents. Clin Exp Gastroenterol 11:289–299; doi: 10.2147/CEG.S171861 .
View Abstract
Topics: Epidemiology
Sacks NC , Cyr PL, Louie AC, Liu Ym Chiarella MT, Sharma A, Chung KC. 2018. Burden of acute myeloid leukemia among older, newly diagnosed patients: Retrospective analysis of data from the 2010-2012 Medicare limited data set. Clin Ther 40(5):692–703.e2.
View Abstract
